Stigma Hinders Rollout Of HIV Pre-Exposure Prophylaxis In Kenya

Devex: Aid groups grapple with stigmatization in HIV prophylaxis rollout
“…[Pre-exposure prophylaxis’ (PrEP)] success in sub-Saharan Africa — the region with the highest burden of HIV — will hinge more on the social than the scientific, though. Researchers and advocates will have to strike a balance in how they market and roll out PrEP. They have to ensure that it reaches stigmatized populations with high HIV transmission rates, such as [men who have sex with men (MSM)] and sex workers. Meanwhile, they must ensure it is not perceived as exclusively a treatment for marginalized groups, which will lower its appeal both within those communities but also to other people who could benefit from it…” (Green, 11/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.